Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-004791
Filing Date
2024-04-05
Accepted
2024-04-05 17:29:28
Documents
6
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240523xdef14a.htm DEF 14A 1094642
2 GRAPHIC tmb-20240523xdef14a_a001.jpg GRAPHIC 6520
3 GRAPHIC tmb-20240523xdef14a_a008.jpg GRAPHIC 53331
4 GRAPHIC tmb-20240523xdef14a_a009.jpg GRAPHIC 55217
5 GRAPHIC tmb-20240523xdef14a_bg001.jpg GRAPHIC 157790
6 GRAPHIC tmb-20240523xdef14a_bg002.jpg GRAPHIC 104931
  Complete submission text file 0001558370-24-004791.txt   1616801
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35366 | Film No.: 24827576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)